Pablo Tebas
Researcher Next ID · RN-028092
Researcher · Immunology and Microbiology
Hospital of the University of Pennsylvania
Philadelphia, Kenya
- Works count
- 378
- Citation count
- 20,162
- H-index
- 77
- i10-index
- 223
Research interests
Publications
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01590-5
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
The Lancet HIV · 2019 · https://doi.org/10.1016/s2352-3018(19)30052-9
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1608243
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1501315
Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
The Journal of Infectious Diseases · 2014 · https://doi.org/10.1093/infdis/jiu051
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1300662
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
The Journal of Infectious Diseases · 2011 · https://doi.org/10.1093/infdis/jir188
Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection
New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0803154
Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370
Antiviral Therapy · 2002 · https://doi.org/10.1177/135965350200700308
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
AIDS · 2000 · https://doi.org/10.1097/00002030-200003100-00005
Current projects
No projects listed.